Literature DB >> 7159000

Cost analysis and a forecast of fractures of the proximal femur in the Province of Middle Finland.

P Lüthje.   

Abstract

In 1980 136 patients with fracture of the proximal part of the femur were treated in the Province of Middle Finland which has a population of 242 439. The total cost of these patients was analysed on the basis of hospital and travelling costs and loss of income. This amounted to 1 728 185 Finnmarks (FIM) ($ 367 066) and the cost per patient was 12 707 FIM ($ 2 700). The number of patients increased during the period 1970-1980 by 157%. If the incidence of fractures of the proximal femur continues to increase at the same rate, there will be about 350 patients with this kind of injury in the Province of Middle Finland in 1990. The number of treatment days will then amount to 5 850 and the total costs will be 4 447 450 FIM ($ 944 638).

Entities:  

Mesh:

Year:  1982        PMID: 7159000

Source DB:  PubMed          Journal:  Ann Chir Gynaecol        ISSN: 0355-9521


  10 in total

1.  COVID-19 in hematopoietic cell transplant recipients.

Authors:  Fevzi Altuntas; Naim Ata; Tugce Nur Yigenoglu; Semih Bascı; Mehmet Sinan Dal; Serdal Korkmaz; Sinem Namdaroglu; Abdulkadir Basturk; Tuba Hacıbekiroglu; Mehmet Hilmi Dogu; İlhami Berber; Kursat Dal; Mehmet Ali Erkurt; Burhan Turgut; Mustafa Mahir Ulgu; Osman Celik; Abdullah Akunal; Suayip Birinci
Journal:  Bone Marrow Transplant       Date:  2020-10-28       Impact factor: 5.483

Review 2.  The immuno-oncological challenge of COVID-19.

Authors:  Lisa Derosa; Cléa Melenotte; Franck Griscelli; Bertrand Gachot; Aurélien Marabelle; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Cancer       Date:  2020-10-02

Review 3.  Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati.

Authors:  Adriana Balduzzi; Erica Brivio; Attilio Rovelli; Carmelo Rizzari; Serena Gasperini; Maria Luisa Melzi; Valentino Conter; Andrea Biondi
Journal:  Bone Marrow Transplant       Date:  2020-04-20       Impact factor: 5.483

4.  Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?

Authors:  P Ivanyi; T Park-Simon; H Christiansen; R Gutzmer; A Vogel; M Heuser; H Golpon; P Hillemanns; J Haier
Journal:  Clin Exp Metastasis       Date:  2021-03-23       Impact factor: 5.150

5.  Impact of the COVID-19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study.

Authors:  M M T J Bartels; R Gal; J M van der Velden; J J C Verhoeff; J J Verlaan; H M Verkooijen
Journal:  Clin Exp Metastasis       Date:  2021-02-25       Impact factor: 5.150

6.  DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma.

Authors:  Sk Kayum Alam; Yongchang Zhang; Li Wang; Zhu Zhu; Christina E Hernandez; Yuling Zhou; Nong Yang; Jian Lei; Xiaoyan Chen; Liang Zeng; Mark A Klein; Luke H Hoeppner
Journal:  Oncogene       Date:  2021-10-21       Impact factor: 9.867

7.  COVID-19 outcomes in patients with hematologic disease.

Authors:  Florent Malard; Alexis Genthon; Eolia Brissot; Zoe van de Wyngaert; Zora Marjanovic; Souhila Ikhlef; Anne Banet; Simona Lapusan; Simona Sestilli; Elise Corre; Annalisa Paviglianiti; Rosa Adaeva; Fella M 'Hammedi-Bouzina; Myriam Labopin; Ollivier Legrand; Rémy Dulery; Mohamad Mohty
Journal:  Bone Marrow Transplant       Date:  2020-05-06       Impact factor: 5.483

8.  An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study.

Authors:  Congkuan Song; Zhe Dong; Hongyun Gong; Xiao-Ping Liu; Xiaorong Dong; Aifen Wang; Yuan Chen; Qibin Song; Weidong Hu
Journal:  J Cancer Res Clin Oncol       Date:  2020-10-11       Impact factor: 4.553

9.  Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.

Authors:  Tingxuan Yin; Yuanjun Li; Ying Ying; Zhijun Luo
Journal:  BMC Infect Dis       Date:  2021-02-22       Impact factor: 3.090

Review 10.  COVID-19: advance in laboratory diagnostic strategy and technology.

Authors:  Kezhen Yi; Yuan Rong; Cheng Wang; Lanxiang Huang; Fubing Wang
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.